title: Treatment of type 2 diabetes in Latin America: a consensus statement by the medical associations of 17 Latin American countries. Latin American Diabetes Association.
abstract: Latin America faces unique challenges in the treatment of type 2 diabetes mellitus. The Asociación Latinoamericana de Diabetes (Latin American Diabetes Association, ALAD) brought together medical associations in 17 countries in Latin America to produce a consensus statement regarding the treatment of type 2 diabetes. The goal of the document is to provide practical recommendations that will guide clinicians through a simple decision-making process for managing patients. The cornerstone elements for therapeutic decision making are: severity of hyperglycemia, clinical condition of the patient (stable or with metabolic decompensation), and body mass index. The consensus includes a section devoted specifically to patients with obesity. Information is presented as highly-relevant clinical questions. The algorithm is based on the scientific recommendations of the 2006 ALAD guidelines (a document prepared using an evidence-based approach) and data from recent randomized controlled studies.
authors.affiliation: Asociación Latinoamericana de Diabetes, Celaya, Guanajuato, México.
authors.forename: Juan Rosas
authors.initials: JR
authors.lastname: Guzmán
authors.forename: Ruy
authors.initials: R
authors.lastname: Lyra
authors.forename: Carlos A
authors.initials: CA
authors.lastname: Aguilar-Salinas
authors.forename: Saulo
authors.initials: S
authors.lastname: Cavalcanti
authors.forename: Felix
authors.initials: F
authors.lastname: Escaño
authors.forename: Marcos
authors.initials: M
authors.lastname: Tambasia
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Duarte
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use; D015992:Body Mass Index; D003131:Combined Modality Therapy; D015897:Comorbidity; D003657:Decision Making; D048909:Diabetes Complications / Q000517:prevention & control; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000178:diet therapy / Q000188:drug therapy / Q000453:epidemiology / Q000628:therapy*; D003927:Diet, Diabetic; D004359:Drug Therapy, Combination; D006442:Glycated Hemoglobin / Q000032:analysis; D006040:Goals; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000145:classification / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D007843:Latin America / Q000453:epidemiology; D008019:Life Style; D024821:Metabolic Syndrome / Q000453:epidemiology / Q000628:therapy; D009765:Obesity / Q000453:epidemiology / Q000628:therapy; D012955:Societies, Medical
chemical_list: D000959:Antihypertensive Agents; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin